Welcome to our dedicated page for Pelican Acquisition II news (Ticker: PLCI), a resource for investors and traders seeking the latest updates and insights on Pelican Acquisition II stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Pelican Acquisition II's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Pelican Acquisition II's position in the market.
Pelican Acquisition II Corporation (Nasdaq: PLCIU) announced that, starting on or about August 12, 2026, holders of units from its initial public offering may elect to separately trade the ordinary shares and rights contained in those units. Units that are not separated will continue trading on the Nasdaq Capital Market under the symbol “PLCIU”.
According to the company, once separated, the ordinary shares are expected to trade under the symbol “PLCI” and the rights under “PLCIR”. Each unit consists of one ordinary share and one right to receive one-tenth (1/10) of one ordinary share. Holders wishing to separate units must have their brokers contact Continental Stock Transfer & Trust Company, the company’s transfer agent. The company stated that this announcement does not constitute an offer to sell or a solicitation to buy securities in any jurisdiction where such actions would be unlawful.
Pelican Acquisition II Corporation (Nasdaq: PLCIU) closed its initial public offering on July 27, 2026, issuing 8,625,000 units at $10.00 per unit, including 1,125,000 units sold through the underwriters’ fully exercised over-allotment option, for aggregate gross proceeds of $86,250,000 before fees and expenses.
Each unit comprises one ordinary share and one right, with each right entitling the holder to receive one-tenth of one ordinary share upon completion of an initial business combination. The units began trading on the Nasdaq Capital Market under the symbol “PLCIU” on July 24, 2026, and the ordinary shares and rights are expected to trade separately under “PLCI” and “PLCIR”, respectively, once separated. EarlyBirdCapital acted as sole book-running manager, and the SEC declared the registration statement effective on July 23, 2026.
Pelican Acquisition II Corporation (NASDAQ: PLCIU) priced its initial public offering of 7,500,000 units at $10.00 per unit on July 23, 2026, for total gross proceeds of $75 million. The units are expected to begin trading on the Nasdaq Capital Market under the ticker “PLCIU” on July 24, 2026.
Each unit includes one ordinary share and one right, with each right entitling the holder to receive one‑tenth of one ordinary share upon completion of an initial business combination. Once separated, the ordinary shares and rights are expected to trade under “PLCI” and “PLCIR”, respectively. The offering is expected to close on July 27, 2026, subject to customary conditions. EarlyBirdCapital is sole book‑running manager and holds a 45‑day option to purchase up to 1,125,000 additional units at the IPO price to cover over‑allotments.